You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 24, 2024

Details for Patent: 8,992,952

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 8,992,952 protect, and when does it expire?

Patent 8,992,952 protects ACUVAIL and is included in one NDA.

This patent has thirteen patent family members in eleven countries.

Summary for Patent: 8,992,952

Title:	Compositions for delivery of therapeutics into the eyes and methods for making and using same
Abstract:	The present invention provides for compositions for administering a therapeutically effective amount of a therapeutic component. The compositions may include an ophthalmically acceptable carrier component; a therapeutically effective amount of a therapeutic component; and a retention component which may be effective to reduce wettability, induce viscosity, increase muco-adhesion, increase meniscus height on a cornea of an eye and/or increase physical apposition to a cornea of an eye of a composition.
Inventor(s):	Vehige; Joseph G. (Laguna Niguel, CA), Chang; James N. (Newport Beach, CA), Graham; Richard (Irvine, CA), Lyons; Robert T. (Laguna Hills, CA), Kuan; Teresa H. (Placentia, CA), Chang; Chin-Ming (Tustin, CA)
Assignee:	Allergan, Inc. (Irvine, CA)
Application Number:	13/933,807
Patent Claim Types: see list of patent claims	Formulation; Compound; Composition;

Drugs Protected by US Patent 8,992,952

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Abbvie	ACUVAIL	ketorolac tromethamine	SOLUTION/DROPS;OPHTHALMIC	022427-001	Jul 22, 2009		RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial	Y				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent 8,992,952

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	444732	⤷ Try a Trial
Australia	2004263149	⤷ Try a Trial
Brazil	PI0413381	⤷ Try a Trial
Canada	2534484	⤷ Try a Trial
Germany	602004023516	⤷ Try a Trial
Denmark	1654002	⤷ Try a Trial
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.